HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fatima Ferreira Selected Research

Seasonal Allergic Rhinitis (Hay Fever)

1/2021High-affinity Bet v 1-specific secretory IgA antibodies in nasal fluids protect against birch pollen allergy.
11/2020Purification and biochemical characterization of Hel a 6, a cross-reactive pectate lyase allergen from Sunflower (Helianthus annuus L.) pollen.
1/2020Defining biomarkers to predict symptoms in subjects with and without allergy under natural pollen exposure.
1/2019Artemisia pollen allergy in China: Component-resolved diagnosis reveals allergic asthma patients have significant multiple allergen sensitization.
10/2017Two Distinct Conformations in Bet v 2 Determine Its Proteolytic Resistance to Cathepsin S.
6/2017Identification of Proteases and Protease Inhibitors in Allergenic and Non-Allergenic Pollen.
8/2014Plantago lanceolata: an important trigger of summer pollinosis with limited IgE cross-reactivity.
3/2014Allergens of weed pollen: an overview on recombinant and natural molecules.
1/2013The fold variant BM4 is beneficial in a therapeutic Bet v 1 mouse model.
3/2010Targeting the cysteine-stabilized fold of Art v 1 for immunotherapy of Artemisia pollen allergy.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Fatima Ferreira Research Topics

Disease

48Hypersensitivity (Allergy)
01/2022 - 03/2002
20Seasonal Allergic Rhinitis (Hay Fever)
01/2021 - 11/2002
3Asthma (Bronchial Asthma)
01/2019 - 02/2007
3Neoplasms (Cancer)
03/2012 - 01/2003
2Infections
12/2020 - 01/2013
2Allergic Rhinitis
01/2020 - 04/2007
2Leukemia
10/2017 - 03/2010
2Anaphylaxis (Anaphylactic Shock)
10/2010 - 09/2003
2Inflammation (Inflammations)
01/2010 - 02/2007
2Food Hypersensitivity (Food Allergy)
01/2006 - 06/2003
1Autoimmune enteropathy
01/2022
1Celiac Disease (Celiac Sprue)
01/2022
1Dust Mite Allergy
03/2021
1Pneumonia (Pneumonitis)
01/2021
1Porcine Reproductive and Respiratory Syndrome (PRRS)
01/2020
1Pain (Aches)
01/2019
1Bacterial Infections (Bacterial Infection)
03/2012
1Diarrhea
01/2012
1Egg Hypersensitivity (Egg Allergy)
04/2011
1Down Syndrome (Down's Syndrome)
11/2007
1Parasitic Diseases (Parasitic Disease)
01/2003
1Immediate Hypersensitivity
03/2002
1Communicable Diseases (Infectious Diseases)
03/2002

Drug/Important Bio-Agent (IBA)

42AllergensIBA
01/2022 - 03/2002
23Immunoglobulin E (IgE)IBA
01/2022 - 03/2002
11VaccinesIBA
03/2021 - 01/2003
10Proteins (Proteins, Gene)FDA Link
01/2022 - 09/2004
8AntibodiesIBA
01/2021 - 01/2003
6Peptides (Polypeptides)IBA
01/2022 - 11/2002
3Peptide Hydrolases (Proteases)FDA Link
06/2017 - 02/2007
2lipid transfer protein (glycolipid transfer protein)IBA
12/2020 - 01/2013
2Biomarkers (Surrogate Marker)IBA
01/2020 - 01/2016
2CytokinesIBA
01/2020 - 12/2010
2DisulfidesIBA
01/2019 - 10/2017
2LipidsIBA
01/2019 - 09/2004
2Profilins (Profilin)IBA
10/2017 - 12/2007
2AntigensIBA
02/2013 - 03/2002
2LatexIBA
12/2011 - 11/2009
2Messenger RNA (mRNA)IBA
12/2010 - 11/2009
2EpitopesIBA
08/2007 - 02/2005
2DNA (Deoxyribonucleic Acid)IBA
08/2007 - 09/2003
2DNA VaccinesIBA
07/2006 - 01/2003
1Glutens (Glutelin)IBA
01/2022
1ProlaminsIBA
01/2022
1Secretory Immunoglobulin A (SIgA)IBA
01/2021
1Pattern Recognition ReceptorsIBA
01/2020
1AlarminsIBA
01/2020
1Chemokine CCL24IBA
01/2020
1Interleukin-8 (Interleukin 8)IBA
01/2020
1Immunoglobulin IsotypesIBA
01/2020
1Immunoglobulins (Immunoglobulin)IBA
01/2020
1ChemokinesIBA
01/2020
1Sevoflurane (Ultane)FDA LinkGeneric
01/2019
1Tramadol (K315)FDA LinkGeneric
01/2019
1KetorolacIBA
01/2019
1Codon (Codons)IBA
01/2018
1Recombinant ProteinsIBA
01/2018
1FlagellinIBA
01/2018
1Protease Inhibitors (Protease Inhibitor)IBA
06/2017
1Cadherins (E-Cadherin)IBA
03/2012
1Interleukin-13IBA
01/2012
1Interleukin-4 (Interleukin 4)IBA
01/2012
1Interleukin-5 (Interleukin 5)IBA
01/2012
1mRNA VaccinesIBA
12/2010
1Diclofenac (SR 38)FDA LinkGeneric
10/2010
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
10/2010
1Pharmaceutical PreparationsIBA
10/2010
1Histocompatibility Antigens Class IIIBA
03/2010
1Cysteine (L-Cysteine)FDA Link
03/2010
1ragweed pollenIBA
06/2009
1Complementary DNA (cDNA)IBA
12/2007
1Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric
11/2007
1CalciumIBA
02/2007
1Biological ProductsIBA
02/2007
1AutoantigensIBA
02/2007
1Anti-Allergic Agents (Antiallergic Agents)IBA
07/2006
1UbiquitinIBA
07/2006
1A-Form DNA (A-DNA)IBA
07/2006
1Therapeutic UsesIBA
07/2006
1OligonucleotidesIBA
02/2005
1NucleotidesIBA
02/2005
1polygalacturonic acid (pectic acid)IBA
09/2004
1DefensinsIBA
09/2004
1LyasesIBA
09/2004
1Interleukin-4 Receptors (Interleukin 4 Receptor)IBA
09/2003
1Immunoglobulin G (IgG)IBA
09/2003

Therapy/Procedure

19Immunotherapy
11/2020 - 11/2002
10Therapeutics
03/2021 - 03/2002
1Anesthesia
01/2019
1Oral Administration
01/2017
1Diet Therapy (Therapy, Diet)
04/2011